# Efficacy and Safety of Qi Zhi Tong Luo Capsule in Vascular Cognitive Impairment

> **NCT04301466** · PHASE2,PHASE3 · COMPLETED · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 362 (actual)

## Conditions studied

- Vascular Cognitive Impairment
- Qi Zhi Tong Luo Capsule
- Randomized Controlled Trial

## Interventions

- **DRUG:** Qi Zhi Tong Luo capsule
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04301466
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-16
- **Primary completion:** 2018-05-30
- **Final completion:** 2018-05-30
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2020-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04301466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04301466, "Efficacy and Safety of Qi Zhi Tong Luo Capsule in Vascular Cognitive Impairment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04301466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*